282 related articles for article (PubMed ID: 35836108)
1. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.
Zhang R; Qu Y; Ji Z; Hao C; Su Y; Yao Y; Zuo W; Chen X; Yang M; Ma G
Cell Mol Biol Lett; 2022 Jul; 27(1):55. PubMed ID: 35836108
[TBL] [Abstract][Full Text] [Related]
2. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
[TBL] [Abstract][Full Text] [Related]
3. Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway.
Zhang K; Zhuo H; Guo J; Wang W; Dai R
Int Heart J; 2024; 65(1):119-127. PubMed ID: 38296564
[TBL] [Abstract][Full Text] [Related]
4. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
[TBL] [Abstract][Full Text] [Related]
5. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
6. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
7. Reduced DNMT1 levels induce cell apoptosis via upregulation of METTL3 in cardiac hypertrophy.
Zhang X; Nie Y; Zhang R; Yu J; Ge J
Heliyon; 2024 Feb; 10(3):e24572. PubMed ID: 38314261
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of METTL3-Mediated m
Wang X; Li Y; Li J; Li S; Wang F
Cardiovasc Drugs Ther; 2023 Jun; 37(3):435-448. PubMed ID: 35066738
[TBL] [Abstract][Full Text] [Related]
9. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
Li AL; Lv JB; Gao L
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
[TBL] [Abstract][Full Text] [Related]
10. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
11. miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.
Huang J; Sun W; Huang H; Ye J; Pan W; Zhong Y; Cheng C; You X; Liu B; Xiong L; Liu S
PLoS One; 2014; 9(4):e94382. PubMed ID: 24728149
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits.
Niu J; Wang B; Wang T; Zhou T
Am J Med Genet B Neuropsychiatr Genet; 2022 Apr; 189(3-4):86-99. PubMed ID: 35591810
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR-34a/DKK1/Wnt-β-catenin signalling.
Fang Q; Liu T; Yu C; Yang X; Shao Y; Shi J; Ye X; Zheng X; Yan J; Xu D; Zou X
J Cell Mol Med; 2020 Mar; 24(6):3678-3691. PubMed ID: 32057178
[TBL] [Abstract][Full Text] [Related]
14. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
15. METTL3-mediated m6A modification promotes processing and maturation of
Gong Y; Jiang Q; Liu L; Liao Q; Yu J; Xiang Z; Luo X
Physiol Genomics; 2022 Sep; 54(9):337-349. PubMed ID: 35759451
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
17. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
[TBL] [Abstract][Full Text] [Related]
19. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
[TBL] [Abstract][Full Text] [Related]
20. Targeting miR-30d reverses pathological cardiac hypertrophy.
Li J; Sha Z; Zhu X; Xu W; Yuan W; Yang T; Jin B; Yan Y; Chen R; Wang S; Yao J; Xu J; Wang Z; Li G; Das S; Yang L; Xiao J
EBioMedicine; 2022 Jul; 81():104108. PubMed ID: 35752105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
